Home ›
NPI 1275697435
NPI deactivated
1275697435
1275697435 was paid $4.43M by Medicaid between Jan 2018 and Oct 2020, across 17 billing codes. Its largest line is J7605, Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms — 46% of everything it billed.
33Billing provider info1275697435
33aNPI1275697435
33bProvider type—
28Total paid$4.43M
24GClaims410,397
24DCodes billed17
24AFirst – last monthJan 2018 – Oct 2020
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 272,237 | $2.91M | |
| 2019 | 132,771 | $1.51M | |
| 2020 | 5,389 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7605 | Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms | 46% | 31,800 | 27,108 | $2.04M |
| J7606 | Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms | 20% | 11,350 | 9,809 | $871K |
| J7626 | Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg | 10% | 37,722 | 32,356 | $453K |
| Q0513 | Pharmacy dispensing fee for inhalation drug(s); per 30 days | 9.6% | 154,756 | 134,232 | $423K |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 6.9% | 72,574 | 62,063 | $305K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 6.2% | 81,326 | 69,928 | $275K |
| G0333 | Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary | <1% | 5,479 | 4,945 | $34K |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 12,896 | 11,034 | $20K |
| J7677 | Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram | <1% | 371 | 60 | $5K |
| J7699 | Noc drugs, inhalation solution administered through dme | <1% | 21 | 19 | $2K |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 102 | 90 | $1K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | <1% | 43 | 43 | $703.58 |
5 more codes
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 270 | $3.13 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 822 | $1.22 |
| A7015 | Aerosol mask, used with dme nebulizer | 0% | 365 | $0.00 |
| E0570 | Nebulizer, with compressor | 0% | 459 | $0.00 |
| A7013 | Filter, disposable, used with aerosol compressor or ultrasonic generator | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.